Moreover, the treatment of PBMCs from MM patients with RV upregulated CD69 expression on NK cells, CD4+ T cells, CD8+ T and NK showed enhanced degranulation against autologous tumor cells [91]. This evidence concerns the gene CD8A and Miyoshi myopathy.